Chronic illness, primarily: 1. Cardiovascular disease 2. Peripheral arterial disease 3. Pulmonary disease (including chronic obstructive pulmonary disease, pulmonary fibrosis) 4. Diabetes 5. Cancer Circulatory System Chronic illness, primarily: 1. Cardiovascular disease 2. Peripheral arterial disease 3. Pulmonary disease (including chronic obstructive
Conditions
Interventions
All participants will attend DCU for 3 days of testing. On Day 1 participants will have a blood sample taken, height, weight, waist and hip circumference measured, complete a questionnaire and some s
Sponsors
Health Service Executive
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Aged 18 years or over 2. Established non-communicable disease
Exclusion criteria
Exclusion criteria: 1. Uncontrolled cardiovascular conditions 2. Significant musculoskeletal or neurological conditions, cognitive decline, mental illness or intellectual disability that restricts participation in a physical training programme
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cardiorespiratory fitness measured using the 6 minute walk test at baseline, 3, 6 and 12 months. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Quality of life measured using Medical Outcomes Study Short Form-12 and disease specific measures (COPD Assessment Tool, Functional Assessment of Cancer Therapy, Walking Impairment Questionnaire) at baseline, 3, 6 and 12 months 2. Daily physical activity measured using accelerometry and the International Physical Activity Questionnaire at baseline, 3, 6 and 12 months 3. Health care utilisation measured using at baseline from patient records and throughout the trial using a healthcare utilisation diary at baseline, 3, 6 and 12 months 4. Blood pressure using a 24 h ambulatory blood pressure monitor at baseline, 3, 6 and 12 months 5. Lipids measured by a blood sample at baseline, 3, 6 and 12 months 6. Body composition measured using body mass index and waist-to-hip ratio at baseline, 3, 6 and 12 months 7. Strength measured using the sit-to-stand test and handgrip test at baseline, 3, 6 and 12 months 8. Flexibility measured using the sit-and-reach test at baseline, 3, 6 and 12 months 9. Cognitive function measured using the cognitive reserve questionnaire, the Attention Network Task and the Luck and Vogel Visual Working Memory Task at baseline, 3, 6 and 12 months 10. Claudication time measured by the Gardner claudication treadmill test at baseline, 3, 6 and 12 months 11. Respiratory function measured by spirometry at baseline, 3, 6 and 12 months 12. Falls risk measured using the Timed Up and Go Test at baseline, 3, 6 and 12 months | — |
Countries
Ireland
Outcome results
None listed